DekaBank Deutsche Girozentrale Buys 153 Shares of The Clorox Company $CLX

DekaBank Deutsche Girozentrale boosted its stake in The Clorox Company (NYSE:CLX) by 0.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 70,048 shares of the company’s stock after purchasing an additional 153 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Clorox were worth $8,387,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CLX. Hsbc Holdings PLC lifted its stake in Clorox by 118.8% in the 1st quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock valued at $159,699,000 after purchasing an additional 589,544 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its stake in Clorox by 101.8% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 1,083,723 shares of the company’s stock valued at $130,123,000 after purchasing an additional 546,761 shares during the last quarter. KBC Group NV lifted its stake in Clorox by 688.7% in the 1st quarter. KBC Group NV now owns 587,679 shares of the company’s stock valued at $86,535,000 after purchasing an additional 513,171 shares during the last quarter. AQR Capital Management LLC lifted its stake in Clorox by 412.1% in the 1st quarter. AQR Capital Management LLC now owns 598,758 shares of the company’s stock valued at $88,167,000 after purchasing an additional 481,846 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its stake in Clorox by 147.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company’s stock valued at $104,107,000 after purchasing an additional 421,453 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.63% of the stock is currently owned by company insiders.

Clorox Trading Down 1.5%

CLX opened at $116.37 on Friday. The Clorox Company has a twelve month low of $116.32 and a twelve month high of $171.37. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The company has a fifty day moving average of $121.30 and a 200-day moving average of $127.15. The stock has a market cap of $14.17 billion, a PE ratio of 17.85, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same period in the prior year, the company posted $1.82 earnings per share. Clorox’s revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a dividend yield of 4.3%. Clorox’s dividend payout ratio is 76.07%.

Analyst Upgrades and Downgrades

Several brokerages recently commented on CLX. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 14th. Citigroup decreased their price target on shares of Clorox from $135.00 to $130.00 and set a “neutral” rating for the company in a research report on Wednesday, October 8th. The Goldman Sachs Group decreased their price target on shares of Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research report on Wednesday, October 1st. JPMorgan Chase & Co. decreased their price target on shares of Clorox from $135.00 to $127.00 and set a “neutral” rating for the company in a research report on Friday, October 10th. Finally, TD Cowen decreased their price target on shares of Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research report on Wednesday, October 1st. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Reduce” and an average price target of $130.20.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.